-+ 0.00%
-+ 0.00%
-+ 0.00%

Syndax Pharmaceuticals shareholders approve 2026 equity incentive plan at annual meeting

PUBT·06/10/2026 20:16:32
Listen to the news
Syndax Pharmaceuticals shareholders approve 2026 equity incentive plan at annual meeting
  • Syndax held its annual meeting on June 10, 2026.
  • Stockholders adopted the 2026 Equity Incentive Plan, effective June 10, 2026, reserving 7,200,000 shares with additional share recycling from prior awards.
  • Stockholders adopted the 2026 Employee Stock Purchase Plan, effective June 10, 2026, replacing the 2015 plan with no share rollover.
  • Stockholders ratified the selection of the company’s independent registered public accounting firm.
  • Stockholders elected Pierre Legault, Michael A. Metzger as directors.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-265852), on June 10, 2026, and is solely responsible for the information contained therein.